Proton therapy to treat ocular cancer
Ocular cancer can be difficult to treat because of its proximity to vital organs and vulnerable tissue. Since protons are more easily controlled than conventional X-rays, they can deliver powerful radiation doses to the tumor site without causing unnecessary damage to surrounding tissue in the eye and head, reducing the risk of side effects. Ocular melanoma is the most common type of eye tumors. Proton therapy allows to preserve the eye and the patient’s vision by limiting damage to the cornea, lens, retina, fovea, or optic nerve. Similarly, it is also a treatment of choice for ocular tumors near the optic nerve or macula.
Your proton therapy community
Campus is the most knowledgeable proton therapy community in the world. With Campus, physicians, medical physicists, dosimetrists, therapists, managers and industry partners will have the tools to share knowledge, and find the information they need at every stage of their proton therapy journey.
Frequently asked questions
In this website, we provide you with extensive litterature and documents about PT research and indications. In particular, we've compiled a series of in-depth white papers exploring the various types of cancers for which proton therapy could be a viable first-choice option.
Protong therapy is indicated in an increasing number of types of tumors. To know more about proton therapy therapy's efficiency and indications, consult our pages on how to start a treatment and the different types of cancers in which oncologist choose proton therapy as a first-choice treatment.
Proton Therapy is indicated in an increasing number of types of tumors. As it minimizes...